Valeant Sells Female Libido Drug Biz Amid Shareholder Suit
Its passion for a female libido drug venture cooled by a shareholder lawsuit, Valeant Pharmaceuticals announced a breakup with Sprout Pharmaceuticals on Monday, handing the business off to a buyer affiliated...To view the full article, register now.
Already a subscriber? Click here to view full article